Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Pharmaceuticals Industry
Nov 21, 2008 04:22 PM
- Cheap On The Lows
Nov 07, 2008 04:26 PM
- A Backlog Of Decisions Is Building At The FDA
Nov 07, 2008 11:48 AM
- Forest Labs Sees Generic Pressure - Analyst Blog
Oct 23, 2008 04:19 PM
- Analyst Comments: Forest Labs, Diamond Offshore, ReneSola, Spansion, Molson Coors, Agrium, Pfizer, Cytori Thera
Sep 25, 2008 02:44 PM
- 2008 Q2 Portfolio Holdings: Bruce Berkowitz, Bob Rodriguez & Mohnish Pabrai
Aug 20, 2008 10:08 AM
- Periodicals Wrap-Up for Tuesday, July 22nd
Jul 22, 2008 10:28 AM
- Failure Sets Replidyne Back
Jun 25, 2008 05:10 PM
- 5th UPDATE: Wyeth, Elan Alzheimer's Drug Effective In Some
Jun 17, 2008 09:44 AM
- 4th UPDATE: Wyeth, Elan Alzheimer's Drug Effective In Some
Jun 17, 2008 08:15 AM
- Forest Laboratories Responds To Unsolicited Mini-Tender Offer
Dec 03, 2008 05:05 PM
- USPTO Confirms Validity of Bystolic(R) Patent
Nov 24, 2008 05:00 PM
- Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA
Oct 27, 2008 08:01 AM
- Zacks Analyst Blog Highlights: Wipro Ltd., Robert Half International Inc., Monarch Casino & Resort Inc., Forest Labs, Inc. And Critical Therapeutics Inc.
Oct 27, 2008 01:14 AM
- Phenomix and Forest Laboratories to Collaborate on Development and Commercialization of Dutogliptin in Diabetes
Oct 23, 2008 08:02 AM
- Forest Laboratories, Inc. Reports Fiscal Second Quarter 2009 Earnings per Share of $0.80
Oct 21, 2008 08:01 AM
- FDA Defers Final Action on milnacipran New Drug Application
Oct 20, 2008 08:01 AM
- Beacon Equity Issues Technical Trade Alerts on Recent Analyst Upgrades: ECL, ADM, NI, EGN, AMED, FRX
Oct 17, 2008 10:20 AM
- Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation
Oct 07, 2008 08:05 AM
- Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 Second Quarter Earnings
Oct 06, 2008 11:36 AM
- Form 4 Murdolo Frank J For: Sep 15 (10K)
Sep 16, 2008 01:23 PM
- Form 3 Murdolo Frank J For: Sep 15 (10K)
Sep 16, 2008 01:20 PM
- Form 4 FOREST LABORATORIES INC For: Aug 15 Filed by: CANDEE WILLIAM J III (10K)
Aug 19, 2008 02:09 PM
- Form 4 FOREST LABORATORIES INC For: Aug 14 Filed by: SALANS LESTER B (10K)
Aug 18, 2008 11:06 AM
- Form 4 FOREST LABORATORIES INC For: Aug 11 Filed by: SALANS LESTER B (10K)
Aug 12, 2008 12:08 PM
- Form 4 FOREST LABORATORIES INC For: Aug 11 Filed by: GOODMAN KENNETH E (10K)
Aug 12, 2008 12:05 PM
- Form 4 FOREST LABORATORIES INC For: Aug 11 Filed by: COHAN GEORGE S (10K)
Aug 12, 2008 12:02 PM
- Form 4 FOREST LABORATORIES INC For: Aug 11 Filed by: GOLDWASSER DAN L (10K)
Aug 12, 2008 12:02 PM
- Form 4 FOREST LABORATORIES INC For: Aug 08 Filed by: CANDEE WILLIAM J III (10K)
Aug 12, 2008 12:00 PM
- Form 4 FOREST LABORATORIES INC For: Aug 11 Filed by: Basgoz Nesli (10K)
Aug 12, 2008 11:59 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
FRX
|
Compare to S&P
|
| YTD |
-35.09 %
|
-0.01 %
|
| 4 Weeks |
2.65 %
|
12.32 %
|
| 12 Weeks |
-21.13 %
|
11.59 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -8.05 %
|
|
EPS Growth in Last Year: -6.98 %
|
|
Sales Growth in Last Quarter: 2.65 %
|
|
Sales Growth in Last Quarter: 8.00 %
|
|
|
